Earnings Call Webcast to Discuss Third Quarter Financial Results Scheduled to Post to Corporate Website on Tuesday, November 18, 2025 NEW YORK, ...
BPL-003 (mebufotenin benzoate nasal spray) granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for ...
Q3 2025 Earnings Call November 10, 2025 4:30 PM ESTCompany ParticipantsDavid Ellison - Chairman & CEOJeffrey S.
Bitwise Asset Management has released its Q3 Corporate Bitcoin Adoption Report, highlighting growing institutional confidence in Bitcoin as an investment and treasury asset. What Happened: The report ...
NEW YORK, NY / ACCESS Newswire / September 23, 2025 / tZERO Group, Inc., a pioneer in blockchain and tokenization innovation for capital markets, today announced that its FINRA member broker-dealer ...
Austria clashes with rest of EU over sanctions Austria wants compensation for Raiffeisen Bank Some diplomats worry asset swap would legitimise Russian courts Raiffeisen shares rise BRUSSELS, Oct 3 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company is a big presence at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback